United States. Congress. House. Committee on Oversight and Government Reform & ProQuest (Firm). (2007). Allegations of waste, fraud, and abuse in pharmaceutical pricing: Financial impacts on federal health programs and the federal taxpayer : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, February 9, 2007. U.S. G.P.O..
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Oversight and Government Reform and ProQuest (Firm). Allegations of Waste, Fraud, and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs and the Federal Taxpayer : Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, First Session, February 9, 2007. Washington: U.S. G.P.O., 2007.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Oversight and Government Reform and ProQuest (Firm). Allegations of Waste, Fraud, and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs and the Federal Taxpayer : Hearing Before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, First Session, February 9, 2007. U.S. G.P.O., 2007.